Paradromics is a developer of a data-rate brain-computer interface technology designed to increase the data transmission rate between brains and machines.
Paradromics is building a direct data interface with the brain to provide technology solutions to unmet medical challenges.
Paradromics was founded in 2015 by Matt Angle. The company is headquartered in Austin, Texas.
Paradromics is combining advanced neuroscience research, specialized microelectronic engineering, and solid medical device and manufacturing experience to build the first high data-rate brain-computer interface (BCI) for long-term medical use.
Paradromics' first commercial product, Connexus® Direct Data Interface (DDI) is a BCI-enabled assistive communication device for severely motor-impaired people.
Paradromics successfully completed testing of its platform, demonstrating the largest ever electrical recording of cortical activity that exceeded more than 60,000 electrode channels in sheep cortex.
Paradromics is backed by Prime Movers Lab, Westcott Investment Group, Dolby Family Ventures, Green Sands Equity, Synergy Ventures, Pureland Global Venture, IT-Farm, Alpha Edison, and others. The company raised $33M in a Series A round on May 18, 2023. This brings Paradromics' total funding to $91.3M to date.